Jean-Frederic Colombel

95PUBLICATIONS
288CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (95)

|Jul 21, 2026
Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

|Jul 01, 2026
Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells.

|Apr 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.

|Apr 13, 2026
Crohn's disease is an obstructive lymphangitis.

Herbert J Van Kruiningen, Jean-Frederic Colombel, Pietro Tonelli

|Mar 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.

Stefan Schreiber, Bruce E Sands, Silvio Danese

|Mar 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.

Marla C Dubinsky, Stefan Schreiber, Andres J Yarur

Pageof 16

Frequent Collaborators

20 joint publications

Ryan Ungaro

16 joint publications

Manasi Agrawal

11 joint publications

Silvio Danese

10 joint publications

Joana Torres